Patents by Inventor Saskia Meyer

Saskia Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED ANTIBODIES AND METHODS OF TREATMENT
    Publication number: 20230022731
    Abstract: The invention is related to CD20 antibodies with improved characteristics. Some embodiments describe antibodies comprising a mouse IgG2; a human IgG1, IgA1 or IgA2 constant region and a variable domain that can bind the epitope “EPANpSEK” on human CD20 expressed on Ramos cells and which antibody has an increased PCD functionality when compared to Rituximab with a constant region of the same isotype.
    Type: Application
    Filed: June 15, 2022
    Publication date: January 26, 2023
    Inventors: Jeannette Henrica Wilhelmina LEUSEN, Peter BOROSS, Johannes Hendrik Marco JANSEN, Saskia MEYER
  • CD20 antibodies
    Patent number: 11414495
    Abstract: CD20 antibodies with improved characteristics. Some embodiments describe antibodies comprising a mouse IgG2; a human IgG1, IgA1 or IgA2 constant region and a variable domain that can bind the epitope “EPANpSEK” (SEQ ID NO:31) on human CD20 expressed on Ramos cells and which antibody has an increased PCD functionality when compared to Rituximab with a constant region of the same isotype.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: August 16, 2022
    Assignee: TIGA TX, INC.
    Inventors: Jeannette Henrica Wilhelmina Leusen, Peter Boross, Johannes Hendrik Marco Jansen, Saskia Meyer
  • CD20 ANTIBODIES
    Publication number: 20190263922
    Abstract: The invention is related to CD20 antibodies with improved characteristics. Some embodiments describe antibodies comprising a mouse IgG2; a human IgG1, IgA1 or IgA2 constant region and a variable domain that can bind the epitope “EPANpSEK” on human CD20 expressed on Ramos cells and which antibody has an increased PCD functionality when compared to Rituximab with a constant region of the same isotype.
    Type: Application
    Filed: September 1, 2017
    Publication date: August 29, 2019
    Inventors: Jeanette Henrica Wilhelmina Leusen, Peter Boross, Johannes Hendrik Marco Jansen, Saskia Meyer